3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid

C63H87ClN8O16 — CID 139315411

IUPAC3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid
SMILESCOc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(=O)N(CCOCCOCCC(=O)O)C1CCN(C(=O)CCn3c4c(c5ccccc53)CN(C)N(C)C4)CC1)[C@]1(C)OC1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C\C=C(\C)C2
InChIInChI=1S/C63H87ClN8O16/c1-39-14-13-17-51(83-10)63(81)36-50(86-61(80)65-63)40(2)59-62(4,88-59)52(35-56(76)69(8)47-33-42(32-39)34-49(82-9)58(47)64)87-60(79)41(3)68(7)53(73)18-19-55(75)71(27-29-85-31-30-84-28-23-57(77)78)43-20-24-70(25-21-43)54(74)22-26-72-46-16-12-11-15-44(46)45-37-66(5)67(6)38-48(45)72/h11-17,33-34,40-41,43,50-52,59,81H,18-32,35-38H2,1-10H3,(H,65,80)(H,77,78)/b17-13-,39-14-/t40-,41+,50+,51-,52+,59?,62+,63+/m1/s1
InChIKeyDBFUUQWVXNTSIW-RRTIDPNQSA-N
MW1247.88 g/mol
LogP5.46
Rot. Bonds21

About 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid

3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid (PubChem CID 139315411) has the molecular formula C63H87ClN8O16 and a molecular weight of 1247.88 g/mol. Its IUPAC name is 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid.

Molecular Properties

Compound Name3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid
PubChem CID139315411
Molecular FormulaC63H87ClN8O16
Molecular Weight1247.88 g/mol
Exact Mass1246.59
IUPAC Name3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid
SMILESCOc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(=O)N(CCOCCOCCC(=O)O)C1CCN(C(=O)CCn3c4c(c5ccccc53)CN(C)N(C)C4)CC1)[C@]1(C)OC1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C\C=C(\C)C2
InChIInChI=1S/C63H87ClN8O16/c1-39-14-13-17-51(83-10)63(81)36-50(86-61(80)65-63)40(2)59-62(4,88-59)52(35-56(76)69(8)47-33-42(32-39)34-49(82-9)58(47)64)87-60(79)41(3)68(7)53(73)18-19-55(75)71(27-29-85-31-30-84-28-23-57(77)78)43-20-24-70(25-21-43)54(74)22-26-72-46-16-12-11-15-44(46)45-37-66(5)67(6)38-48(45)72/h11-17,33-34,40-41,43,50-52,59,81H,18-32,35-38H2,1-10H3,(H,65,80)(H,77,78)/b17-13-,39-14-/t40-,41+,50+,51-,52+,59?,62+,63+/m1/s1
InChIKeyDBFUUQWVXNTSIW-RRTIDPNQSA-N
XLogP5.46
TPSA264.26 Ų
H-Bond Donors3
H-Bond Acceptors18
Rotatable Bonds21
Heavy Atoms88
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001247.88
LogP ≤ 55.46
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid?
The IUPAC name of 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid (CID 139315411) is 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid.
What is the SMILES notation for 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid?
The canonical SMILES for 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid is COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(=O)N(CCOCCOCCC(=O)O)C1CCN(C(=O)CCn3c4c(c5ccccc53)CN(C)N(C)C4)CC1)[C@]1(C)OC1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C\C=C(\C)C2.
What is the InChIKey of 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid?
The InChIKey is DBFUUQWVXNTSIW-RRTIDPNQSA-N. The full InChI is InChI=1S/C63H87ClN8O16/c1-39-14-13-17-51(83-10)63(81)36-50(86-61(80)65-63)40(2)59-62(4,88-59)52(35-56(76)69(8)47-33-42(32-39)34-49(82-9)58(47)64)87-60(79)41(3)68(7)53(73)18-19-55(75)71(27-29-85-31-30-84-28-23-57(77)78)43-20-24-70(25-21-43)54(74)22-26-72-46-16-12-11-15-44(46)45-37-66(5)67(6)38-48(45)72/h11-17,33-34,40-41,43,50-52,59,81H,18-32,35-38H2,1-10H3,(H,65,80)(H,77,78)/b17-13-,39-14-/t40-,41+,50+,51-,52+,59?,62+,63+/m1/s1.
What are the key properties of 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid?
3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid has a molecular weight of 1247.88 g/mol, XLogP of 5.46, 21 rotatable bonds, 3 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[2-[[4-[[(2S)-1-[[(1S,2R,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-4-oxobutanoyl]-[1-[3-(2,3-dimethyl-1,4-dihydropyridazino[4,5-b]indol-5-yl)propanoyl]piperidin-4-yl]amino]ethoxy]ethoxy]propanoic acid is sourced from PubChem (CID 139315411), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).